TITLE

Chapter 2: Isn't There Anything to Keep Me from Being So Hungry All the Time?

AUTHOR(S)
Hunter, William
PUB. DATE
February 2005
SOURCE
When Dieting Isn't Enough: Medications & Surgeries for Weight Lo;2005, p31
SOURCE TYPE
Book
DOC. TYPE
Article
ABSTRACT
This article provides information on the classes of drugs used to treat obesity that reduces hunger. For the most part, chemical substances within the body control hunger. The body produces them in response to the cues such as the amount of sugar in the bloodstream. Most of the drugs that work by reducing hunger take advantage of blood chemistry to change the hunger patterns of the patient. The U.S. Food and Drug Administration, however, has only approved one medication for long-term use that acts by reducing how hungry one feels. Called sibutramine, it is sold under the brand name Meridia. A combination therapy called Fen-Phen, which combined Phentermine with Fenfluramine, was also quite effective in reducing weight in the people taking it.
ACCESSION #
15690121

 

Related Articles

  • Pulmonary Hypertension Associated with Use of Phentermine. Woo-Dae Bang; Ji-Ye Kim; Hee-Tae Yu; Sung-Soo Cho; Ji-Yong Jang; Chang-Myung Oh; Boyoung Joung; Hyuk-Jae Chang // Yonsei Medical Journal;11/1/2010, Vol. 51 Issue 6, p971 

    Weight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of breath and was diagnosed with pulmonary hypertension. Three months ago, she had been taking...

  • Fen-phen: Risky for dieters in any form.  // Consumer Reports;Sep97, Vol. 62 Issue 9, p6 

    Reports on the dangers of the diet drug fen-phen and its herbal counterpart, Herbal Fen-Phen. Where Herbal Fen-Phen is sold; Why the US Food and Drug Administration recommended against the use of fen-phen; Deaths related to the use of fen-phen.

  • Every New Mexico drugstore sued over phen-fen. Conlan, Michael F. // Drug Topics;12/7/98, Vol. 142 Issue 23, p24 

    Reports on the state lawsuit against 281 community pharmacies in New Mexico filed at the District Court in Santa Fe in 1998. Allegations of the plaintiffs regarding the manufacturers and sellers of fenfluramine-phentermine; Highlights of the case.

  • Phen-fen frenzy. Clive, Teagan // Joe Weider's Muscle & Fitness;Jan97, Vol. 58 Issue 1, p100 

    Focuses on the phentermine-fenfluramine (phen-fen) drug combination for weight loss. Effectiveness of the combination; Side effects; Disagreement between physicians on the drug combination; Background information on the phen-fen saga; Drug's potential for abuse. INSETS: Who gets phen-fen--and...

  • Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status. Whigham, L. D.; Dhurandhar, N. V.; Rahko, P. S.; Atkinson, R. L. // International Journal of Obesity;May2007, Vol. 31 Issue 5, p850 

    Background:Obesity treatment with single drugs produces weight losses of about 8–10% of initial body weight. Few studies of combinations of drugs for treating obesity have been published. The combination of phentermine, an adrenergic agent, and fenfluramine, a serotonergic agent,...

  • Safety of drug therapies used for weight loss and treatment of obesity. Ioannides-Demos, Lisa L.; Proietto, Joseph; Tonkin, Andrew M.; McNeil, John J. // Drug Safety;2006, Vol. 29 Issue 4, p277 

    Some of the medications used for weight loss in the management of obesity have been associated with unacceptable morbidity and mortality. Safety concerns have led to the withdrawal of aminorex, followed by the fenfluramines in 1997, and phenylpropanolamine (norephedrine) in 2000. Aminorex was...

  • Fen-phen study creates a ferment.  // Drug Topics;7/21/97, Vol. 141 Issue 14, p7 

    Reports that the Mayo Clinic has issued a report linking heart valve problems with fenfluramine and phentermine. Warnings given by the United States Federal Drug Administration to watch patients who are taking the combination; Information on the class action lawsuits filed against Wyeth-Ayerst...

  • Just one bad apple in combo blamed.  // Drug Topics;7/21/97, Vol. 141 Issue 14, p7 

    Reports that Michael Anchors is challenging reports linking the fen-phen duo, to heart valve problems. Perception that only fenfluramine is responsible for the coronary complications; Use of phentermine.

  • Diet centers rethink `fat' drugs.  // Drug Topics;7/21/97, Vol. 141 Issue 14, p7 

    Reports on the effect of the Mayo Clinic report linking heart valve damage to fen-phen, on commercial diet centers. Reactions of Nutri-System company; Recommendations made by Jenny Craig to physicians at the centers.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics